Here are relevant reports on : talent-outsourcing-market
-
Healthcare BPO Market by Size, Share, Trends by Outsourcing Models, Life Science (R&D, Manufacturing, Supply Chain, Sales & Marketing (Analytics)), Provider (Patient Care, RCM), Payer (Claims Management, Billing & Accounts), Region - Global Forecast to 2030
The global healthcare BPO market, valued at US$337.6 billion in 2024, stood at US$417.7 billion in 2025 and is projected to advance at a resilient CAGR of 10.7% from 2025 to 2030, culminating in a forecasted valuation of US$694.3 billion by the end of the period. Factors such as the increasing pressure to control rising healthcare costs, the transition to ICD-10 coding standards, the anticipated adoption of ICD-11, and the growing trend of outsourcing in the pharmaceutical and biopharmaceutical sectors are expected to drive market expansion during the forecast period.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Healthcare IT Outsourcing Market by Application [Provider (EHR, RCM, LIMS) Payer (CRM, Claims Management, Fraud Detection, Billing) Life Science (ERP, CTMS, CDMS) Operational (SCM, BPM) & Infrastructure (IMS, Cloud Computing)] & Industry - Global Forecast To 2018
Outsourcing is an emerging phenomenon in the healthcare information technology market. It is a screening process wherein an organization selects the most efficient third-party service provider to effectively operate its management and administrative unit. The global market is forecast to grow at a CAGR of 7.6%, to reach $50.4 Billion by 2018 from $35 Billion in 2013. The health insurance industry, healthcare systems industry, and pharmaceutical industry are driving the HCIT outsourcing market.
- Published: August 2013
- Price: $ 4950
- TOC Available:
-
Food Diagnostics Market by Type (Systems, Test Kits, and Consumables), Testing Type (Safety and Quality), Site (Outsourcing Facility and Inhouse), Food Tested (Meat, Poultry & Seafood, Dairy Products, Processed Food) and Region - Global Forecast to 2028
The global food diagnostics market is projected to reach USD 23.5 billion by 2028, at a CAGR of 7.7% during the forecast period. Major key players operating in the food diagnostics market include Bio-Rad Laboratories Inc. (US), Thermo Fisher Scientific Inc. (US), Shimadzu Corporation (Japan), Neogen Corporation (US), BioMerieux (France), Agilent Technologies Inc. (US), Merck KGaA (Germany), QIAGEN (Germany), Bruker (US), and Danaher (US).
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Food Pathogen Safety Testing Equipment and Supplies Market by Type (Systems, Test Kits, and Microbial Culture Media), Site (In-House, Outsourcing Facility, and Government Labs), Food Tested and Region - Global Forecast to 2028
The food pathogen safety testing equipment and supplies market is projected to reach USD 10.4 billion by 2028, at a CAGR of 7.1% during the forecast period. Major key players operating in the food pathogen safety testing equipment and supplies market include Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Neogen Corporation (US), BIOMÉRIEUX (France), Agilent Technologies, Inc. (US), QIAGEN (Germany), Shimadzu Corporation (Japan), Bruker (US), and PerkinElmer Inc. (US),
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Revenue Cycle Management (RCM) Market by Offering [Product (Front, Mid, Back-end Solutions), Outsourcing Service], Enterprise Size [Large, SMEs], Technology [AI, Non-AI], End User [Inpatient, Outpatient, Payer, Pharmacy] & Region - Global Forecast to 2030
The global revenue cycle management market, valued at US$58.27 billion in 2024, stood at US$65.49 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2024 to 2030, culminating in a forecasted valuation of US$117.50 billion by the end of the period.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Regulatory Environment and Impact Analysis- Sterile Packaging Market Standards & Regulations, Regional & National Regulatory Bodies - Market Analysis & Forecast to 2020
The market for sterile medical packaging is estimated to grow from USD 26.55 Billion in 2015 to reach USD 35.07 Billion by 2020, at an estimated CAGR of 5.72%. The segmentation considered for this report is based on region. The region consists of North America, Europe, Asia-Pacific, and Rest of the World (RoW). The base year considered for the study is 2014 and the market size is projected from 2015 to 2020.
- Published: April 2016
- Price: $ 4950
- TOC Available:
-
Cloud Manufacturing Market - By Technology (ASP, AM, NM, Mgrid, Virtualization, Internet of Things (Iot), Cloud Computing, Enterprise Resource Planning (ERP), Business Intelligence (BI)) - Advancements, Market Forecasts and Analysis (2014 - 2019)
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Eye Tracking Market by Offering (Hardware, Software, Services), Tracking Type (Remote and Mobile), Application (Assistive Communication, and Human Behavior & Market Research), Vertical, and Geography- Global Forecast to 2025
The Eye Tracking Market is expected to grow from USD 368 million in 2020 to USD 1,098 million by 2025, at a CAGR of 24.5% during the forecast period. A few key players operating in the eye tracking market are Tobii (Sweden), EyeTracking (US), SR Research (Canada), Seeing Machines (Australia), PRS IN VIVO (France), Smart Eye (Sweden), EyeTech Digital Systems (US), Eyegaze (US), Ergoneers (Germany), ISCAN (US), iMotions (Denmark), and Lumen Research (UK).
- Published: July 2020
- Price: $ 4950
- TOC Available:
-
Breast Cancer Liquid Biopsy Market by Circulating Biomarkers, Region, End User, Investments, Market Dynamics, Platform Comparison (NGS, PCR), Competitive Landscape (Acquisition, Mergers, Collaboration, Competitive technology) & Geography
The global breast cancer liquid biopsy market is projected to grow at a CAGR of 23.1%. Factors such as increasing prevalence of breast cancer, increasing preference for noninvasive procedures, initiatives undertaken by government and global health organizations, technological advancements to augment market revenues, rising emphasis on personalized medicine in clinical practice, and increased funding for liquid biopsy R&D are driving the growth of the breast cancer liquid biopsy market. The key players in the global breast cancer liquid biopsy market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US), Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDx Health SA (US).
- Published: August 2018
- Price: $ 4950
- TOC Available:
-
Glycomics Market / Glycobiology Market by Product (Enzymes (Glycosidases, Transferases), Instruments (Mass Spectrometry, Chromatography, Arrays), Kits, Carbohydrates, Reagents), Application (Drug Discovery, Diagnostics), End User - Global Forecast to 2027
The global glycomics market in terms of revenue was estimated to be worth $1.8 Billion in 2022 and is poised to reach $3.7 billion by 2027, growing at a CAGR of 15.5% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: November 2022
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
